Sumitomo Mitsui Trust Group
MED icon

Sumitomo Mitsui Trust Group’s Medifast MED Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-990
Closed -$280K – 1194
2021
Q2 		$280K Buy
+990
New +$268K ﹤0.01% 1153

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sumitomo Mitsui Trust Group's MED Position: Q3 2021 in Review

Sumitomo Mitsui Trust Group sold out of Medifast (MED) in Q3 2021, closing a stake of 990 shares — an estimated $280K sold.

Sumitomo Mitsui Trust Group first reported a position in MED in Q2 2021 and held it in 1 quarter. The position peaked at $280K in Q2 2021. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

  • Sumitomo Mitsui Trust Group reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 990 Medifast shares in Q3 2021, an estimated $280K.
  • Sumitomo Mitsui Trust Group first reported a position in Medifast in Q2 2021 and held it in 1 quarter.
  • Sumitomo Mitsui Trust Group's Medifast position peaked at $280K in Q2 2021.
  • 296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2021, filed 25 Oct 2021.